SP

SP Plus Corporation Awarded Five-Year Contract at San Francisco International Airport

Retrieved on: 
Monday, December 4, 2023

CHICAGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- SP+® Corporation (SP+) (Nasdaq: SP), a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced its five-year contract for ground transportation management, parking, and concierge/ambassador services at San Francisco International Airport (SFO) in San Mateo County, California.

Key Points: 
  • CHICAGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- SP+® Corporation (SP+) (Nasdaq: SP), a best-in-class technology and operations management provider of mobility services for aviation, commercial, hospitality, and institutional clients throughout North America and Europe, today announced its five-year contract for ground transportation management, parking, and concierge/ambassador services at San Francisco International Airport (SFO) in San Mateo County, California.
  • SP+ worked collaboratively and efficiently with the long-term and proven local ACBDE/MBE/WBE/LBE.
  • Welcoming an estimated 46 million passengers in 2023, SFO is the largest airport in the San Francisco Bay-area, and the second-busiest airport in California.
  • Operating under a newly formed Joint Venture (JV) agreement known as SP PLUS SF Joint Venture (“SP+SF”), between SP+ and long-term and proven local ACBDE/MBE/WBE/LBE firm, and SF Parking, LLC.

AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions

Retrieved on: 
Tuesday, December 19, 2023

AscellaHealth , a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit , a dedicated provider of exceptional outsourced services to the UK government.

Key Points: 
  • AscellaHealth , a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit , a dedicated provider of exceptional outsourced services to the UK government.
  • This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public organizations around the world.
  • “4Merit Solutions reflects our shared commitment to providing unparalleled services to governments and public entities worldwide.
  • “4Merit Solutions aspires to establish exemplary standards in delivering efficient, secure and transparent solutions across various industries and public service sectors, such as justice, immigration, health, transport and defense,” says Colin Dobell, CEO, 4Merit.

AscellaHealth Identifies Key Health Trends for 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry

Retrieved on: 
Tuesday, December 19, 2023

AscellaHealth a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024, as industry stakeholders brace for transformative changes across the healthcare ecosystem.

Key Points: 
  • AscellaHealth a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024, as industry stakeholders brace for transformative changes across the healthcare ecosystem.
  • As the industry shifts toward value-based and outcome-based contracts, AscellaHealth foresees enhanced patient access to these innovative treatments.
  • Addressing the pivotal issue of managing costs associated with specialty drug spend, AscellaHealth brings forth customisable services for payers.
  • With an extensive background in specialty pharmacy and rare disease expertise, AscellaHealth is pioneering innovative cost-containment strategies.

StackPath Introduces Dedicated Hosts for Edge Compute

Retrieved on: 
Wednesday, December 20, 2023

DALLAS, Dec. 20, 2023 /PRNewswire/ -- StackPath (SP//), the industry-leading edge computing platform, today announced the addition of Dedicated Hosts for its edge computing products.

Key Points: 
  • DALLAS, Dec. 20, 2023 /PRNewswire/ -- StackPath (SP//), the industry-leading edge computing platform, today announced the addition of Dedicated Hosts for its edge computing products.
  • SP// Edge Compute Dedicated Hosts lets a customer deploy SP// Edge VMs or SP// Edge Containers hosted on a physical server dedicated to just that customer to ensure optimal and consistent performance.
  • SP// Edge Compute Dedicated Hosts feature a physically separate computing environment for enhanced data security and deterministic cloud performance to handle usage spikes, consistently high traffic, optimized end-user experiences, and privacy.
  • Existing or new customers can contact StackPath Sales to learn more and begin using SP// Edge Compute Dedicated Hosts for their unique edge computing needs.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - RPT, CSTR, PCTI, SP

Retrieved on: 
Saturday, November 11, 2023

Under the terms of the agreement, RPT shareholders are expected to receive 0.6049 shares of Kimco per share they own.

Key Points: 
  • Under the terms of the agreement, RPT shareholders are expected to receive 0.6049 shares of Kimco per share they own.
  • Under the terms of the agreement, CSTR shareholders will receive 1.155 shares of Old National per share they own.
  • SP Plus Corp. (Nasdaq: SP ), relating to its proposed sale to Metropolis Technologies, Inc.
  • Under the terms of the agreement, SP shareholders will receive $54.00 in cash per share they own.

AscellaHealth Identifies Key Trends Worth Watching in 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry

Retrieved on: 
Thursday, December 14, 2023

AscellaHealth , a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024.

Key Points: 
  • AscellaHealth , a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024.
  • AscellaHealth anticipates an accelerated number of clinical trials, with a substantial focus on oncology and rare diseases.
  • As the industry shifts toward value-based and outcome-based contracts, AscellaHealth foresees enhanced patient access to these innovative treatments.
  • With an extensive background in specialty pharmacy and rare disease expertise, AscellaHealth is pioneering innovative cost-containment strategies.

AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increased Access to Daraprim® and Enhanced Patient Outcomes

Retrieved on: 
Tuesday, December 12, 2023

Proprietary technology and patient engagement tools provide actionable data metrics for program optimization every step of the way.”

Key Points: 
  • Proprietary technology and patient engagement tools provide actionable data metrics for program optimization every step of the way.”
    This revolutionary patient support program goes well beyond a typical information hotline or static web information.
  • Akeel Mithani, CEO of Tilde adds, “access to medications in the US has become increasingly complex.
  • At Tilde Sciences, our mission is to be on the forefront of identifying solutions that simplify access for critically ill patients.
  • Ultimately, we are confident that the people at AscellaHealth and Optime Care share our genuine care and concern for rare disease patients.

GE Vernova–MYTILINEOS Consortium Awarded £1bn Contract to Construct the UK’s First High-Capacity East Coast Subsea Link

Retrieved on: 
Tuesday, December 12, 2023

Specifically, the GE Vernova–MYTILINEOS consortium was selected to supply and construct two High-Voltage Direct Current (HVDC) converter stations for Eastern Green Link 1 (EGL1), a joint venture between National Grid Electricity Transmission and SP Transmission.

Key Points: 
  • Specifically, the GE Vernova–MYTILINEOS consortium was selected to supply and construct two High-Voltage Direct Current (HVDC) converter stations for Eastern Green Link 1 (EGL1), a joint venture between National Grid Electricity Transmission and SP Transmission.
  • HVDC provides the most efficient and reliable means of transmitting large amounts of power long distances subsea.
  • "Together with our consortium partner MYTILINEOS, we are honored to have been awarded the HVDC contract for EGL1, one of the UK’s largest ever transmission projects.
  • EGL1 is a key part of the new network infrastructure in supporting UK’s efforts for decarbonization and security of supply.

Arco to Provide Supplemental Materials for Extraordinary General Meeting of Shareholders

Retrieved on: 
Thursday, November 16, 2023

The Company began mailing the notice and proxy statement relating to the EGM (collectively, the “Proxy Statement”) on or about November 10, 2023.

Key Points: 
  • The Company began mailing the notice and proxy statement relating to the EGM (collectively, the “Proxy Statement”) on or about November 10, 2023.
  • 2 at the EGM, was inadvertently omitted from the Proxy Statement as mailed to the Company’s shareholders.
  • The Surviving Company Amended and Restated Memorandum and Articles of Association can be accessed in Arco’s website ( https://investor.arcoplatform.com/financials/others/ ) or by clicking here .
  • 2, or concerning any other matter related to the EGM, should contact the Company’s Investor Relations Department at [email protected] .

SP NUTRACEUTICALS ENTERS NEXT CHAPTER OF BUSINESS GROWTH WITH NEW INVESTMENT PARTNER, CHOPRAX VENTURES, AND APPOINTMENT OF NEW CEO AND BOARD OF DIRECTORS

Retrieved on: 
Tuesday, December 5, 2023

BURLINGTON, ON, Dec. 5, 2023 /PRNewswire/ -- Today, SP Nutraceuticals announced a strategic partnership and equity agreement with ChopraX Ventures, led by its renowned clinician and Chairman Dr. Deepak Chopra, a pioneer at the forefront of medicine for the past 50 years. Simultaneously, SP Nutraceuticals announced a new slate of senior leadership and advisory members, including the appointment of Darren Contardo, current President of the company, as the new Chief Executive Officer, effective as of November 6, 2024. Darren will retain the President title. SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.

Key Points: 
  • SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.
  • "We are excited to collaborate with SP Nutraceuticals and actively pursue breakthrough innovations in metabolic health," said David Lubotta, Managing Partner of ChopraX Ventures.
  • "I am honored to step into the position of CEO of SP Nutraceuticals in this exciting phase of growth," said Darren Contardo, CEO of SP Nutraceuticals.
  • New board members include:
    Trevor Clarke, former CEO of SP Nutraceuticals, will now serve as the Executive Director and Corporate Secretary.